Although the deleterious vasoconstrictive effects of cell-free, hemoglobin-based blood substitutes have been appreciated, the systemic effects of chronic hemolysis on nitric oxide bioavailability have not been considered or quantified. Central to this investigation is the understanding that nitric oxide reacts at least 1,000 times more rapidly with free hemoglobin solutions than with erythrocytes. We hypothesized that decompartmentalization of hemoglobin into plasma would divert nitric oxide from homeostatic vascular function. We demonstrate here that plasma from patients with sickle-cell disease contains cell-free ferrous hemoglobin, which stoichiometrically consumes micromolar quantities of nitric oxide and abrogates forearm blood flow responses to nitric oxide donor infusions. Therapies that inactivate plasma hemoglobin by oxidation or nitric oxide ligation restore nitric oxide bioavailability. Decompartmentalization of hemoglobin and subsequent dioxygenation of nitric oxide may explain the vascular complications shared by acute and chronic hemolytic disorders.
To determine the relative contributions of endothelial-derived nitric oxide (NO) vs. intravascular nitrogen oxide species in the regulation of human blood flow, we simultaneously measured forearm blood flow and arterial and venous levels of plasma nitrite, LMW-SNOs and HMW-SNOs, and red cell S-nitrosohemoglobin (SNO-Hb). Measurements were made at rest and during regional inhibition of NO synthesis, followed by forearm exercise. Surprisingly, we found significant circulating arterial-venous plasma nitrite gradients, providing a novel delivery source for intravascular NO. Further supporting the notion that circulating nitrite is bioactive, the consumption of nitrite increased significantly with exercise during the inhibition of regional endothelial synthesis of NO. The role of circulating S-nitrosothiols and SNO-Hb in the regulation of basal vascular tone is less certain. We found that low-molecular-weight S-nitrosothiols were undetectable and S-nitroso-albumin levels were two logs lower than previously reported. In fact, S-nitroso-albumin primarily formed in the venous circulation, even during NO synthase inhibition. Whereas SNO-Hb was measurable in the human circulation (brachial artery levels of 170 nM in whole blood), arterial-venous gradients were not significant, and delivery of NO from SNO-Hb was minimal. In conclusion, we present data that suggest (i) circulating nitrite is bioactive and provides a delivery gradient of intravascular NO, (ii) S-nitrosoalbumin does not deliver NO from the lungs to the tissue but forms in the peripheral circulation, and (iii) SNO-Hb and S-nitrosothiols play a minimal role in the regulation of basal vascular tone, even during exercise stress. N itric oxide (NO) is a soluble gas synthesized in endothelial cells from the amino acid L-arginine by the constitutive calcium and calmodulin-dependent enzyme NO synthase (1). In their seminal experiment, Furchgott and Zawadzki (2) found that strips of rabbit aorta with intact endothelium relaxed in response to acetylcholine but constricted in response to the same agonist when the endothelium had been rubbed off. The substance responsible for acetylcholine-stimulated relaxation was initially called endothelium-derived relaxant factor but was subsequently found to include NO (3, 4). The importance of endothelium-derived NO in the regulation of coronary and systemic vasodilator tone has been demonstrated experimentally by regional inhibition of its synthesis with N G -monomethyl-Larginine (L-NMMA), which competes with L-arginine as the substrate for NO synthase (5, 6).Because of the instability and short half-life of NO, there has been considerable interest in the role of more stable NO adducts and metabolites that could circulate and regulate vascular tone in vivo. It has recently been proposed that NO is stabilized by covalent bonding with thiols such as glutathione, cysteine, albumin, and hemoglobin (7-10). These low-and highmolecular-weight S-nitrosothiols (LMW-SNOs and HMWSNOs) are believed to play a role in the stabilization and deli...
To quantify the reactions of nitric oxide (NO) with hemoglobin under physiological conditions and to test models of NO transport on hemoglobin, we have developed an assay to measure NOhemoglobin reaction products in normal volunteers, under basal conditions and during NO inhalation. NO inhalation markedly raised total nitrosylated hemoglobin levels, with a significant arterial-venous gradient, supporting a role for hemoglobin in the transport and delivery of NO. The predominant species accounting for this arterial-venous gradient is nitrosyl(heme)hemoglobin. NO breathing increases S-nitrosation of hemoglobin -chain cysteine 93, however only to a fraction of the level of nitrosyl(heme)hemoglobin and without a detectable arterial-venous gradient. A strong correlation between methemoglobin and plasma nitrate formation was observed, suggesting that NO metabolism is a primary physiological cause of hemoglobin oxidation. Our results demonstrate that NO-heme reaction pathways predominate in vivo, NO binding to heme groups is a rapidly reversible process, and S-nitrosohemoglobin formation is probably not a primary transport mechanism for NO but may facilitate NO release from heme. In the last several years, the interactions of nitric oxide (NO) and hemoglobin have become the subject of much interest. A model has been recently proposed by Stamler and colleagues suggesting that NO is transported on hemoglobin by binding to the highly conserved -chain cysteine 93 residue, forming Snitrosohemoglobin (SNO-Hb) (1-4). According to this theory, NO carried on hemoglobin -cysteine 93 is delivered from the lungs to the microvasculature where, on deoxygenation in the tissues, the S-nitroso linkage is weakened. This allows the NO molecules, free or complexed to small thiols, to diffuse through the erythrocytes to the vascular walls, causing vasodilation of the microvasculature and subsequent recruitment of more erythrocytes. The model also posits that in the venous circulation, deoxygenated hemoglobin preferentially binds NO at the heme group to form nitrosyl(heme)hemoglobin [Hb(FeII)NO], as total NO-modified hemoglobin levels were found to be equal in the arterial and venous blood of rats (2). However, recent studies argue that NO either is not released from SNO-Hb during deoxygenation (5) or that any NO released from SNO-Hb is actively scavenged by oxyhemoglobin and fails to affect vascular tone (6). Furthermore, to date in vivo SNO-Hb measurements have been performed only in the Sprague-Dawley rat, thus the physiological significance in humans has been questioned.The reaction of NO with hemoglobin to form SNO-Hb is in addition to two other well-characterized NO reactions: with oxyhemoglobin to form methemoglobin (FeIII) and nitrate ion and with deoxyhemoglobin to form Hb(FeII)NO. This second reaction is also the subject of much current research. Yonetani and his research group and Kosaka and colleagues have shown that Hb(FeII)NO is a six-coordinate species (iron binds four nitrogens, a proximal histidine, and NO) and that on d...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.